Company profile: Enlight Biosciences
1.1 - Company Overview
Company description
- Provider of technology platforms and software, including Entrega for enabling oral delivery of complex biological molecules and drug substances, KNODE for connecting users with experts and their content within and beyond R&D organizations, and Peerin, a Twitter application that helps professionals discover industry-specific insights by identifying and ranking high-value conversations and trends.
Products and services
- Peerin: A Twitter application that helps professionals discover industry-specific insights by identifying and ranking high-value conversations and trends, offering prioritized visibility into influential discussions and trends
- KNODE: A software tool that connects users with experts and their content, facilitating access to expertise within and beyond R&D organizations to help locate relevant experts and associated content
- Entrega: A technology platform enabling oral delivery of complex biological molecules and drug substances, potentially transforming chronic disease management by moving administration of such compounds to oral routes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Enlight Biosciences
Biosynthetic Technologies
HQ: United States
Website
- Description: Provider of biobased synthetic molecules and oils made from organic fatty acids found in plant oils for lubricant, chemical, and cosmetics applications. Products include Estolides and BioEstolides, sustainable industrial lubricant base oils, metalworking fluid additives, hydraulic oils, and personal care ingredients offering stability, lubricity, wear protection, and biodegradability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosynthetic Technologies company profile →
Recombia
HQ: United States
Website
- Description: Provider of synthetic biology and genome engineering solutions, offering yeast strain optimization, metabolic engineering, and microbial strain engineering to enhance industrial fermentation, produce natural products, and support various industrial applications using rationally designed genetic modifications with high precision, efficiency, and throughput.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Recombia company profile →
BridGene Biosciences
HQ: United States
Website
- Description: Provider of chemoproteomics-driven small-molecule discovery and development via the IMTAC platform that screens small molecules against all proteins in live cells; a covalent small-molecule library targeting diverse amino acids; live-cell screening and quantitative mass spec analysis services; and drug development for undruggable targets, particularly in oncology, with partnerships such as Takeda.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BridGene Biosciences company profile →
Diagenode
HQ: Belgium
Website
- Description: Provider of instruments and reagents for life science research and molecular diagnostics, including ultrasound-based sample preparation and DNA/RNA shearing (Bioruptor), high molecular weight DNA shearing for long-read sequencing (Megaruptor), automation for ChIP and epigenetic assays (IP-Star), epigenomics profiling services, and ChIP and DNA methylation kits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagenode company profile →
Luminex
HQ: United States
Website
- Description: Provider of biological testing technologies and products for the life sciences and diagnostics industries, including its Multi-Analyte Profiling (xMAP) open-architecture multiplexing technology enabling simultaneous analysis of up to 500 bioassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luminex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Enlight Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Enlight Biosciences
2.2 - Growth funds investing in similar companies to Enlight Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Enlight Biosciences
4.2 - Public trading comparable groups for Enlight Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →